Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Spirapril, sold under the brand name Renormax among others, is an ACE inhibitor antihypertensive drug used to treat hypertension. It belongs to dicarboxy group of ACE inhibitors.[citation needed]
Chemistry & Overview
Explore the main themes, entities and connections around Spirapril. Start with the topic map, then use the sections below for research and deeper semantic analysis.
Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the full topic structure. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
See the strongest relationship patterns around the current topic before diving into the raw triples.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
ace renal name renormax drug group inhibitors use spiraprilat hepatic routes administration oral converted mw-parser-output antihypertensive hypertension sold brand among
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Spirapril | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Spirapril | AHFS/Drugs.com | International Drug Names | 1.00 | infobox |
| Spirapril | ATC code | C09AA11 (WHO) | 1.00 | infobox |
| Spirapril | Bioavailability | 50% | 1.00 | infobox |
| Spirapril | CAS Number | 83647-97-6 Y | 1.00 | infobox |
| Spirapril | ChEBI | CHEBI:135756 | 1.00 | infobox |
| Spirapril | ChEMBL | ChEMBL431 Y | 1.00 | infobox |
| Spirapril | ChemSpider | 4470933 Y | 1.00 | infobox |
| Spirapril | CompTox Dashboard (EPA) | DTXSID1044300 | 1.00 | infobox |
| Spirapril | DrugBank | DB01348 N | 1.00 | infobox |
| Spirapril | Elimination half-life | 30 to 35 hours | 1.00 | infobox |
| Spirapril | Excretion | Hepatic and renal | 1.00 | infobox |
| Spirapril | Formula | C22H30N2O5S2 | 1.00 | infobox |
| Spirapril | IUPHAR/BPS | 6575 | 1.00 | infobox |
| Spirapril | KEGG | D08529 Y | 1.00 | infobox |
| Spirapril | Legal status | In general: ℞ (Prescription only) | 1.00 | infobox |
| Spirapril | Metabolism | converted to spiraprilat | 1.00 | infobox |
| Spirapril | Molar mass | 466.61 g·mol−1 | 1.00 | infobox |
| Spirapril | Pregnancy category | D | 1.00 | infobox |
| Spirapril | PubChem CID | 5311447 | 1.00 | infobox |
| Spirapril | Routes of administration | Oral | 1.00 | infobox |
| Spirapril | Trade names | Renormax | 1.00 | infobox |
| Spirapril | UNII | 96U2K78I3V | 1.00 | infobox |
These clusters group vocabulary that occurs around closely connected concepts in the source material.
Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.